Erratum to: Diacerein: Benefits, Risks and Place in the Management of Osteoarthritis. An Opinion-Based Report from the ESCEO (Drugs & Aging, (2016), 33, 2, (75-85), 10.1007/s40266-016-0347-4)

Karel Pavelka; Olivier Bruyère; Cyrus Cooper; John A. Kanis; Burkhard F. Leeb; Emmanuel Maheu; Johanne Martel-Pelletier; Jordi Monfort; Jean Pierre Pelletier; René Rizzoli; Jean Yves Reginster

Article

Erratum to: Diacerein: Benefits, Risks and Place in the Management of Osteoarthritis. An Opinion-Based Report from the ESCEO (Drugs & Aging, (2016), 33, 2, (75-85), 10.1007/s40266-016-0347-4)

Drugs and Aging

DOI: 10.1007/s40266-017-0457-7

5Citations

20Readers

Get full text

Abstract

In the original publication the affiliation for John A. Kanis was incorrectly published. This previously read: WHO Collaborating Centre for Metabolic Bone Diseases, University of Sheffield Medical School, Sheffield, UK. Should read: Centre for Metabolic Bone Diseases, University of Sheffield Medical School, Sheffield, UK.

Cite

CITATION STYLE

APA

Pavelka, K., Bruyère, O., Cooper, C., Kanis, J. A., Leeb, B. F., Maheu, E., … Reginster, J. Y. (2017, May 1). Erratum to: Diacerein: Benefits, Risks and Place in the Management of Osteoarthritis. An Opinion-Based Report from the ESCEO (Drugs & Aging, (2016), 33, 2, (75-85), 10.1007/s40266-016-0347-4). Drugs and Aging. Springer International Publishing. https://doi.org/10.1007/s40266-017-0457-7

Erratum to: Diacerein: Benefits, Risks and Place in the Management of Osteoarthritis. An Opinion-Based Report from the ESCEO (Drugs & Aging, (2016), 33, 2, (75-85), 10.1007/s40266-016-0347-4)

Abstract

Cite

Register to see more suggestions